Results 61 to 70 of about 83,725,006 (209)

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT<sub>2A</sub> Receptor Ligand. [PDF]

open access: yesMolecules
Many drug discovery efforts have identified potentially promising molecules; however, a common limitation of these reports is the lack of further experimental confirmation of pharmacokinetic properties and behavioral effects of discovered compounds.
Zięba A   +10 more
europepmc   +2 more sources

Safety pharmacology of acute mescaline administration in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber   +4 more
wiley   +1 more source

The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function. [PDF]

open access: yesPLoS ONE, 2014
There is considerable interest in defining new agents or targets for antithrombotic purposes. The 5-HT2A receptor is a G-protein coupled receptor (GPCR) expressed on many cell types, and a known therapeutic target for many disease states.
Olivia A Lin   +4 more
doaj   +1 more source

5-HT2A Receptor Gene Polymorphisms and Irritable Bowel Syndrome

open access: yesJournal of Clinical Gastroenterology, 2011
The aim of the study was to investigate the potential association between single nucleotide polymorphisms of the 5-HT2A receptor gene and susceptibility to irritable bowel syndrome (IBS) in the Greek population.Serotonin [5-hydroxytryptamine (5-HT)] is the main mediator involved in the pathophysiology of IBS.
Markoutsaki, T.   +4 more
openaire   +3 more sources

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

2,5-Dimethoxy-4-iodoamphetamine (DOI) Inhibits ∆9-Tetrahydrocannabinol-Induced Catalepsy-Like Immobilization in Mice

open access: yesJournal of Pharmacological Sciences, 2007
The effect of the serotonin 5-HT2A/2C-receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) on ∆9-tetrahydrocannabinol (THC)-induced catalepsy-like immobilization was studied in mice.
Nobuaki Egashira   +5 more
doaj   +1 more source

Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca2+ Signaling

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives Antipsychotic‐induced salivary dysfunction such as hyposalivation is a prevalent clinical challenge that severely compromises oral health and quality of life. Although typical and atypical antipsychotics have their therapeutic target in the central nervous system, their direct molecular mechanisms within the salivary glands remain ...
Chaelin Chung   +4 more
wiley   +1 more source

Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors

open access: yesBiomolecules & Biomedicine, 2017
Lerimazoline is a sympathomimetic drug that belongs to the imidazoline class of compounds, and is used as a nasal decongestant. Studies on lerimazoline are rare, and its pharmacological profile is not completely understood.
Eldina Rizvić   +3 more
doaj   +1 more source

Effect of Blonanserin on Neurotrophic Factors in Patients With Non‐Responsive First‐Episode Schizophrenia Treated With Early Risperidone Monotherapy—A Randomized Controlled Trial

open access: yesInternational Journal of Methods in Psychiatric Research, Volume 35, Issue 4, December 2026.
ABSTRACT Objective To investigate the efficacy of Blonanserin in patients with schizophrenia who were refractory to Risperidone monotherapy and its effects on various neurotrophic factors. Methods A total of 120 patients with first‐episode schizophrenia who were hospitalized in our hospital from January 2022 to December 2023 and did not respond to ...
Yaxue Wei   +7 more
wiley   +1 more source

5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling

open access: yes, 2018
The serotonin 5-HT2A and glutamate mGlu2 receptors continue to attract particular attention, given their implication in psychosis associated with schizophrenia and the mechanism of action of atypical antipsychotics and a new class of antipsychotics ...
Marin P.   +33 more
core   +1 more source

Home - About - Disclaimer - Privacy